Alberto Zambon

机构：University of Padua, University of Washington, Azienda Ospedale - Università Padova · ORCID：0000-0001-7096-5201

发表论文 179 篇 · 总被引 10985 次 · h-index 45

代表论文

• 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias (2025 · European Heart Journal · 被引 475)
• Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment (2025 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 24)
• Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry (2024 · European Journal of Preventive Cardiology · 被引 16)
• Lessons from PROMINENT and prospects for pemafibrate (2024 · Cardiovascular Diabetology · 被引 14)
• Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy (2024 · Advances in Therapy · 被引 13)
• Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry (2025 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 8)